Fig. 4 Dose-dependent recombination in the Tg(pax2a:CreERT2)#19 and Tg(pax2a:CreERT2)#45 lines by TAM.
(a) Double transgenic embryos bearing the red-to-green reporter and the Tg(pax2a:CreERT2)#19 alleles show strong EGFP expression in the diencephalon after application of 5 μM TAM at mid-gastrulation stages. Application of 0.5 μM TAM or 0.05 μM TAM at the same stage, results in reduced EGFP expression or single EGFP-positive cells, respectively. (b) Double transgenic embryos bearing the red-to-green reporter and the Tg(pax2a:CreERT2)#45 alleles show strong EGFP expression in rhombomere 3 and 5 after application of 5 μM TAM at mid-gastrulation stages. Application of 0.5 μM TAM at the same stage, results in single EGFP-positive cells. a, b Dorsal views of double transgenic embryos at 24 hpf. Scale bar, 30 μm.